Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Overview of attention for article published in Annals of Oncology, October 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news: 4 news outlets
blogs: 2 blogs
policy: 2 policy sources
twitter: 12 X users

patent: 1 patent
guideline: 8 clinical guideline sources
podcasts: 4 podcasts

Readers on

mendeley: 366 Mendeley

So far, Altmetric has seen 9 Guidelines that reference this research output.

AGO Breast Committee recommendations for the surgical therapy of breast cancer: Working Group on Gynecologic Cancers (AGO) update 2026

Clinical guideline published by Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) on 06 May 2026

The Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) is a dedicated community within the German Society for Gynecology and Obstetrics and the German Cancer Society. It focuses on gynecological oncology, providing guidelines, recommendations, and support for professionals and patients alike.

Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HR+/HER2− Early Breast Cancer 2025

Clinical guideline published by Canadian Breast Cancer Network (CBCN) on 12 Feb 2026

CBCN is Canada's only patient-directed national breast cancer health charity.

SEOM-GEICAM-SOLTI clinical guidelines for early-stage breast cancer (UPDATE 2025)

Clinical guideline published by Sociedad Española de Oncología Médica (SEOM) on 29 Nov 2025

The Sociedad Española de Oncología Médica (SEOM) is a leading organization in Spain dedicated to oncology. It provides comprehensive resources, including clinical guidelines, educational programs, and research support, aimed at improving cancer care and treatment outcomes for patients.

Systemic treatment of breast cancer: professional guideline.

Clinical guideline published by German Cancer Society on 15 Jul 2025

The German Cancer Society is a nonprofit organization dedicated to cancer research and treatment, comprising around 8,000 members from various medical and scientific fields. It focuses on clinical practice guidelines, cancer prevention, and certification in cancer care, promoting collaboration in oncology.

This page shows the most recent posts that mention this research output. Click here to find out how to access more activity, including 5 additional posts.